PRONULIFE® GlukoSolu-Blood Sugar Control and Health Maintenance

Product description

Our R&D Center has selected powerful probiotic strains (Bifidobacterium animalis subsp. lactis CP-9, Lactobacillus johnsonii MH-68, and Lactobacillus salivarius AP-32) known for their effective blood sugar control in type 1 diabetes. Studies have shown that Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 protect β-cells, stabilize blood sugar, and improve liver and kidney functions affected by diabetes.

Clinical research demonstrates that PRONULIFE®GlukoSolu probiotics improve glycated hemoglobin levels, stabilize blood sugar, reduce inflammatory hormones, and enhance anti-inflammatory hormones. NGS analysis reveals increased abundance of beneficial gut bacteria.
*For probiotics targeting type 2 diabetes, please contact us.

→ See More: https://lihi.cc/r6P71/IIN_GlukoSolu
Read more

Specifications

Categories Clinical trials; Contract manufacturing; Probiotics
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from Taiwan, China
Product Applications Food Supplements; Natural Products
Product Certifications Gluten-free; Halal; Health & Safety (GMP, HAACP and equivalents); Health claims; Natural; Quality assurance; Sustainable; Traceable

More products from Glac Biotech Co, Ltd.

View all our products (20)

Products from other suppliers

PRONULIFE® GlukoSolu-Blood Sugar Control and Health Maintenance

Contact information

Address

Email

Telephone

Website

View all contact information